Atrial fibrillation in COVID-19 patients receiving remdesivir, matched case-control analysis

Bistrović, Petra; Manola, Šime; Papić, Ivan; Jordan, Ana; Ortner Hadžiabdić, Maja; Lucijanić, Marko

doi:10.1016/j.ajem.2022.04.051

Pregled bibliografske jedinice broj: 1227610

Atrial fibrillation in COVID-19 patients receiving remdesivir, matched case-control analysis

Bistrović, Petra; Manola, Šime; Papić, Ivan; Jordan, Ana; Ortner Hadžiabdić, Maja; Lucijanić, Marko

Atrial fibrillation in COVID-19 patients receiving remdesivir, matched case-control analysis // American journal of emergency medicine, 59 (2022), 182-183 doi:10.1016/j.ajem.2022.04.051 (međunarodna recenzija, pismo uredniku, stručni)

CROSBI ID: 1227610 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Atrial fibrillation in COVID-19 patients receiving remdesivir, matched case-control analysis

Autori
Bistrović, Petra ; Manola, Šime ; Papić, Ivan ; Jordan, Ana ; Ortner Hadžiabdić, Maja ; Lucijanić, Marko

Izvornik
American journal of emergency medicine (0735-6757) 59 (2022); 182-183

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, pismo uredniku, stručni

Ključne riječi
remdesivir ; atrial fibrillation ; COVID-19

Sažetak
Research has been observed to cause bradycardia, with some research suggesting it might not be a negative phenomenon. We investigated impacts of bradycardia in remdesivir treated patients with atrial fibrillation and report these findings in this paper.

Izvorni jezik
Engleski

Znanstvena područja
Kliničke medicinske znanosti

POVEZANOST RADA

Ustanove:
Farmaceutsko-biokemijski fakultet, Zagreb,
Stomatološki fakultet, Zagreb,
Medicinski fakultet, Zagreb,
Klinička bolnica "Dubrava"

Profili:

Petra Bistrović (autor)